Kevin Church
Chief Tech/Sci/R&D Officer en ATHIRA PHARMA, INC. .
Fortuna: 219 901 $ al 31/03/2024
Perfil
Kevin Church is currently the Chief Scientific Officer at Athira Pharma, Inc. He started this position in 2023.
Prior to his current role, he obtained an undergraduate degree from the University of Idaho in 2006.
He then pursued a doctorate degree from the School of Molecular Biosciences, which he completed in 2016.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ATHIRA PHARMA, INC.
0.21% | 14/02/2024 | 80 256 ( 0.21% ) | 219 901 $ | 31/03/2024 |
Cargos activos de Kevin Church
| Empresas | Cargo | Inicio |
|---|---|---|
| ATHIRA PHARMA, INC. | Chief Tech/Sci/R&D Officer | 31/01/2023 |
Formación de Kevin Church.
| University of Idaho | Undergraduate Degree |
| School of Molecular Biosciences | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ATHIRA PHARMA, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Kevin Church
